國家衛生研究院 NHRI:Item 3990099045/8338

NHRI > Institute of Biotechnology and Pharmaceutical Research > Hsing-Pang Hsieh > Periodical Articles > Item 3990099045/8338

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/8338

Title:	BPR-3P0128 inhibits RNA-dependent RNA polymerase elongation and VPg uridylylation activities of Enterovirus 71
Authors:	Balaji, VA;Chen, GW;Hsieh, PT;Horng, JT;Hsu, JTA;Hsieh, HP;Chen, TC;Weng, KF;Shih, SR
Contributors:	Institute of Biotechnology and Pharmaceutical Research
Abstract:	Enterovirus 71 (EV71) infections can cause hand, foot, and mouth disease with severe neurological complications. Because no clinical drug is available for treating EV71 infections, developing an efficient antiviral medication against EV71 infection is crucial. This study indicated that 6-bromo-2-[1-(2,5-dimethylphenyl)-5-methyl-1H-pyrazol-4-yl] quinoline-4-carboxylic acid (BPR-3P0128) exhibits excellent antiviral activity against EV71 (EC50 = 0.0029 μM). BPR-3P0128 inhibits viral replication during the early post infection stage, targets EV71 RNA-dependent RNA polymerase and VPg uridylylation, and also reduces viral RNA accumulation levels and inhibits viral replication of EV71.
Date:	2014-12
Relation:	Antiviral Research. 2014 Dec;112:18-25.
Link to:	http://dx.doi.org/10.1016/j.antiviral.2014.10.003
JIF/Ranking 2023:	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0166-3542&DestApp=IC2JCR
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:000346943900003
Cited Times(Scopus):	http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84908296574
Appears in Collections:	[Hsing-Pang Hsieh] Periodical Articles [John Tsu-An Hsu] Periodical Articles

Files in This Item:

File	Description	Size	Format
SDO0166354214002836.pdf		1106Kb	Adobe PDF	590	View/Open

Loading...